About
AngioScore Inc. is a medical device company based in Fremont, California, founded in 2003. The company specializes in developing, manufacturing, and marketing scoring balloon catheters for treating cardiovascular and peripheral artery diseases. Its flagship product, the AngioSculpt Scoring Balloon Catheter, features a semi-compliant balloon combined with a nitinol scoring element. This design allows for precise luminal enlargement by scoring plaque, which helps minimize slippage during procedures. AngioScore's products are utilized in both coronary and peripheral interventional markets, addressing arterial blockages in the heart and legs. The AngioSculpt devices have been used in over 350,000 procedures globally, effectively managing complex conditions such as critical limb ischemia and chronic total occlusions. In 2014, AngioScore was acquired by The Spectranetics Corporation, enhancing its market presence and distribution capabilities while continuing to serve healthcare providers and patients worldwide.
Technologies
Keywords
Company Information
-
Employees 54
-
Founded 2003
-
Annual Revenue $21666000
-
Total Funding $12000002
Location
5055 Brandin Ct, Fremont, California, United States, 94538